No statistically significant results in a reduction in CRP were observed in the treated groups to conclude the positive effects of pooled fetal WJMSCs-derived sEVs preparations on fasting serum CRP levels in MetS rats, as shown in Figure 9. This evidence concerns the gene CRP and metabolic syndrome.